APYX MEDICAL CORP (APYX) Stock Analyst Ratings
NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 76% to APYX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 102.65% above the current price.
APYX was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about APYX.
In the previous month the buy percentage consensus was at a similar level.
APYX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-17 | BTIG | Initiate | Neutral |
| 2024-09-16 | JMP Securities | Reiterate | Market Perform |
| 2023-11-10 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-14 | Stephens & Co. | Initiate | Overweight |
| 2023-06-15 | Lake Street | Maintains | Buy |
| 2023-05-24 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2023-05-12 | Lake Street | Maintains | Buy -> Buy |
| 2022-08-12 | Piper Sandler | Maintains | Overweight |
| 2022-07-19 | Lake Street | Maintains | Buy |
| 2022-05-20 | Lake Street | Initiate | Buy |
| 2021-08-13 | JMP Securities | Maintains | Market Outperform |